Hunan Cancer Hospital

This early-stage trial is testing a new combination of two drugs for people with a specific type of advanced breast cancer that has spread and has gotten worse after their first line of treatment. The study aims to see if combining a newer targeted drug (sacituzumab govitecan) wi…

This study is testing whether combining a targeted pill called firmonertinib with radiation therapy can help control stage III lung cancer that cannot be surgically removed and has specific, less common genetic changes. It aims to see if this approach can delay cancer growth and …